the aid library

LIST OPTIONS

Filter

9885

Stratégie opérationnelle du Programme mondial de lutte contre le paludisme 2024-2030

World Health Organisation (WHO) (2024) C_WHO

En tant que département technique de l'OMS chargé du paludisme, le Programme mondial de lutte contre le paludisme a un rôle important à jouer dans la conduite de la riposte mondiale contre cette maladie. Grâce à ses actions directes et à son réseau, il peut façonner l'écosystème du paludi... more

Download (31)

View PDF (14)

Manual para la estratificación según el riesgo de malaria y la eliminación de focos de transmisión

Pan American Health Organization (PAHO) (2022) C_WHO

Todos los países de la Región de las Américas en los que la malaria es endémica han asumido el reto de eliminar la enfermedad y de poner en marcha medidas para orientar sus programas y estrategias de salud en esa dirección. En este manual se explica cómo ejecutar las medidas con vistas a logra... more

Download (38)

View PDF (21)

Nota técnica sobre la aceleración de la eliminación de P. falciparum en las Américas

Pan American Health Organization (PAHO) (2023) C_WHO

Esta nota técnica busca guiar a los programas nacionales de malaria y a las organizaciones implicadas en el apoyo de los esfuerzos para la eliminación de la malaria en la Región de las Américas, a fin de que intensifiquen las acciones políticas/estratégicas e implementen los cambios operativos... more

Download (33)

View PDF (38)

Tackling malaria in countries hardest hit by the disease: ministerial conference report, Yaoundé, Cameroon, 6 March 2024

World Health Organisation (WHO) (2024) C_WHO

The Malaria Ministerial Conference, co-hosted by WHO and the Government of Cameroon on 6 March 2024, brought together more than 400 stakeholders, including Ministers of Health and senior representatives from the African countries hardest hit by malaria, global health leaders, scientists, civil socie... more

Download (417)

View PDF (885)

WHO supports the immunization of 1 million people against cholera in Zambia

World Health Organization WHO (2018) C_WHO

WHO supports Zambia in vaccinating 1 million people in Lusaka against cholera to combat an outbreak that began in October 2017, causing 2,672 cases and 63 deaths. Two million vaccine doses were provided by Gavi. WHO and the Zambia National Public Health Institute are improving water access, sanitati... more

Download (679)

View PDF (1731)

The Use of Cholera Rapid Diagnostic Tests

Global Task Force on Cholera Control (GTFCC) World Health Organisation (WHO) (2016) C_WHO

The Interim Guidance on Cholera Rapid Diagnostic Tests (RDTs) by the Global Task Force on Cholera Control (GTFCC) provides recommendations for using RDTs to detect cholera in areas with limited laboratory capacity. It highlights the advantages of RDTs, such as rapid detection (within 30 minutes), ea... more

Download (571)

View PDF (1640)

Target Product Profile (TPP) for the development of improved Cholera rapid diagnostic tests

Global Task Force on Cholera Control (GTFCC) World Health Organisation (WHO) (2017) C_WHO

The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ... more

Download (208)

View PDF (210)

Health Department provides update on Cholera outbreak in South Africa

Health Department Republic of South Africa (2023) C2

The South African Department of Health reports a decline in cholera cases, with only one confirmed case out of 28 suspected cases in the last 10 days as of July 5, 2023. However, authorities urge continued vigilance, emphasizing hygiene, especially during mass gatherings. Since February 2023, South... more

Download (69)

View PDF (53)

Cholera Outbreak in Haiti. Situation Report, n. 8 (13 March 2024)

Pan American Health Organization (PAHO) (2024) C_WHO

The report provides an update on the cholera outbreak in Haiti as of January and February 2024. A total of 79,411 suspected cases have been reported, with 4,608 confirmed cases and 1,172 deaths across all 10 departments. The most affected regions include Ouest, Centre, Artibonite, and Nord, with chi... more

Download (214)

View PDF (223)

SITREP N° 05 DU 22 au 23 JUILLET 2023 Épidémies de Choléra, Shigellose et Salmonellose au Congo

World Health Organisation (WHO) (2023) C_WHO

Le rapport décrit la situation épidémiologique au Congo entre le 22 et le 23 juillet 2023, mettant en évidence les épidémies de choléra, de shigellose et de salmonellose. Il mentionne 19 cas confirmés de choléra, 3 de shigellose et 3 de salmonellose, ainsi que 63 cas d'intoxication alimenta... more

Download (158)

View PDF (204)

Actualización epidemiológica - Cólera - 25 de octubre de 2022

Pan American Health Organization (PAHO) (2022) C_WHO

Desde la notificación de los dos primeros casos confirmados de Vibrio cholerae O1 en el área del gran Puerto Príncipe el 2 de octubre de 2022, al 23 de octubre de 2022, el Ministerio de Salud de Haití (Ministère de la Santé Publique et de la Population, MSPP por sus siglas en francés), inform... more

Download (577)

View PDF (833)

Evidence of the risks and benefits of vaccinating pregnant women with WHO pre-qualified cholera vaccines during mass campaigns

Global Task Force on Cholera Control (GTFCC) World Health Organisation (WHO) (2016) C_WHO

The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv... more

Download (225)

View PDF (242)

Prise en charge clinique de la diarrhée aigue

Organisation Mondiale de la Santé OMS (2004) C_WHO

Le document fournit des lignes directrices sur la gestion des diarrhées aiguës, mettant en avant des solutions de réhydratation orale (SRO) améliorées avec une osmolarité réduite et la supplémentation en zinc. Il souligne leur efficacité pour réduire la durée et la gravité des épisodes ... more

Download (654)

View PDF (1005)

Gestion des dépouilles mortelles lors de catastrophes : manuel pratique à l’usage des premiers intervenants. 2ième éd., rév.

Cordner, S.; Coninx, R.; Kim, J.-J. et al. (Éd.) Organisation mondiale de la santé (OMS), Organisation panaméricaine de la santé, Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge (2016) C_WHO

La deuxième édition de ce manuel fournit des directives simples, concrètes et faciles à suivre pour la récupération et le stockage des corps des personnes décédées lors de catastrophes et l’enregistrement des informations les concernant, l’objectif étant d’aider les premiers interven... more

Download (1133)

View PDF (2404)

Health Preparedness For El Niño Event 2015-2016

World Health Organization (WHO) (2015) C_WHO

The WHO report on health preparedness for El Niño 2015-2016 describes the impact of this weather phenomenon on global public health. Strong El Niño events lead to extreme weather conditions, including droughts, floods, and storms, which increase the risk of diseases such as cholera, malaria, and d... more

Download (92)

View PDF (284)

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease

Institute for Health Metrics and Evaluation - University of Washington The Lancet (2017) CC2

The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a significant portion of global mortality, particular... more

Download (108)

View PDF (117)

La Situation des enfants dans le monde 2023

UN Children's Fund UNICEF (2024) CC

The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID... more

Download (1796)

View PDF (3140)

Cómo combatir el cólera: Presentación y manejo clínico para el brote de cólera en Haití de 2010

CDC, U.S. Department of Health and Human Services (2010) C_CDC

The document titled "Cómo combatir el cólera" (How to Combat Cholera) provides comprehensive guidelines on the clinical presentation and management of cholera, particularly in the context of the 2010 Haiti outbreak. It emphasizes the importance of rapid rehydration as a lifesaving measure, deta... more

Download (97)

View PDF (105)

Estado Mundial de la Infancia 2023

UN Children's Fund UNICEF (2024) CC

Download (344)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more